Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and Radiation for Brain Metastases
NCT00031967Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- May 2002
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of melatonin in brain metastases, sponsored by NRG Oncology. Started May 2002; status: completed.
02
Drugs
melatonin
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00031967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031967.